Analytical Assays
A comprehensive portfolio of analytical testing assays to drive insights throughout all stages of drug development
We employ high-parameter flow cytometry to deconvolute diverse cell populations, while immunohistochemistry and plate-based tools assess tissue changes. Next Generation Sequencing and 4D Proteomics can be used to generate hypotheses that drive oncology drug strategy.
Preclinical and Clinical Endpoint Assays & Analysis
Endpoint analyses form a critical component in both preclinical and clinical oncology research studies. These analyses provide researchers with quantifiable measures to assess the treatment efficacy across multiple parameters and derive safe and accurate insights to guide critical decisions on your programs. Working with Champions gives you access to:
-
Scientific consultation throughout study design, execution, and data interpretation
-
Competitive turnaround times
-
State-of-the-art analytical laboratories
FLOW CYTOMETRY
Interrogate up to 30 parameters on each individual cell simultaneously within a sample
HISTOLOGY & IMMUNOHISTOCHEMISTRY
Assess target protein expression within a tissue of interest
LUMINEX & ELISA
Evaluate secreted proteins such as cytokines, growth factors, and chemokines in plate-based assays
NEXT GENERATION SEQUENCING
Generate personalized medicine strategies through bioinformatic and computational analyses
4D PROTEOMICS
Utilize mass-to-charge ratio, retention time, ionic strength, and ion mobility to identify and quantify proteins
WESTERN BLOT
Assess protein expression with picogram level sensitivity in only microliters of sample
DNA DAMAGE ASSAYS
Measure activity of agents involved in DNA damage repair
IMAGING
COLONY FORMING UNIT (CFU) ASSAY
Measure clonal composition shifts in response to cytotoxic therapies
CELL VIABILITY/PROLIFERATION
Evaluate the viability or proliferation of cells throughout the duration of ex vivo assays
QUANTITATIVE REAL-TIME PCR (QPCR)
Determine the absolute quantity of target DNA in each sample
What is an endpoint assay?
How do I choose the best endpoint analysis for my study?
The best endpoint analysis for your study will depend on the goal of the study and the mechanism of action of your agent. For example, you will want to measure your agent ability to kill tumor cells with a cell viability assay ex vivo or by tumor growth inhibition in vivo; additionally, you may want to use flow cytometry and imaging to measure immune cell population shifts/movement if you are testing an IO agent, or use comet assay to measure DNA damage if testing an agent that targets the DNA damage/repair mechanism, or use NGS or proteomics and Luminex/ELISA to measure changes in DNA or protein expression if you agent is expected to modify DNA/protein expression level. Our experts can help you identify the best endpoint analysis and help you plan your study efficiently and successfully.